(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXCELLOS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EXCELLOS

ST13

US500000097805943

Class

1, 5, 39, 40, 42, 44

Filing

97805943

Registration

7431789

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

08/12/2026

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 39, 40, 42, 44

Filing date

02/22/2023

Registration date

07/02/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/02/2024

Last transaction

08/12/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/25/2022

First use in commerce

01/25/2022

Drawing code

4

Owner type

16

Owner location

SAN DIEGO, CA, US

Examiner

MURRAY, DAVID T

Law office

M40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

EXCELLOS LABS, LLC
Excellos, Incorporated

Representatives

Richard P. Sybert GORDON REES SCULLY MANSUKHANI LLP

Technical classification

Nice Classes

Class 1Class 5Class 39Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Cells and biological tissuebloodlymphocytesT cellsstem cellsT cell receptors for use in scientificlaboratorymedical research; Cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestioncell isolationcell storagecell population expansion and amplificationcell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolationcell storagewhite blood cell and lymphocyte population expansion and amplificationwhite blood cell and lymphocyte growth and stimulation; lymphocytes in the nature of cells for scientific and research use; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for clinical trialscientificlaboratorymedical research; Biological reagents for scientific and medical research use; Biological preparationsmononuclear cellsprogenitor cellsantibody preparations for use in medical clinical trials and medical research in the field of immunotherapy

Class 5

Pharmaceutical preparations for immunotherapymononuclear cellsprogenitor cellsantibody preparations for medical purposes

Class 39

distributing human blood products for otherstransportation of blood products for others; Storage and retrieval of bloodperipheral blood mononuclear cells (PBMCs)tissue and stem cells for scientificlaboratorymedical research

Class 40

bio-manufacturing for othersmanufacturing of adoptive cell and personalized adoptive cell therapies

Class 42

Medical researchnamely research in the field of the blood process of patients' blood to isolate lymphocytes for the use in immunotherapy for therapeutic medical research

Class 44

Medical servicesprocessing of stem cells and white blood cells for use by others; stem cell and white blood cell storagestem cell and white blood cell bank services; collection and preservation of human bloodblood componentsapheresisperipheral blood mononuclear cells (PBMCs)plasma and bone marrow

Publications

History of USPTO decisions and trademark events.

27 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/12/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/16/2024

PUBO

PUBLISHED FOR OPPOSITION

04/16/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/08/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/08/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/08/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/08/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/08/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

03/07/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

01/23/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/08/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

01/08/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/08/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

01/08/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/04/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/04/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/04/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/21/2023

GNRT

NON-FINAL ACTION E-MAILED

11/21/2023

CNRT

NON-FINAL ACTION WRITTEN

11/21/2023

DOCK

ASSIGNED TO EXAMINER

11/21/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/13/2023

NWAP

NEW APPLICATION ENTERED

02/25/2023

Continuous trademark protection

Get notified about every new filing that threatens EXCELLOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.